Metraipolis › archive › dc_580be2af7829

Tripterygium glycosides: recent advances in mechanisms, therapeutic applications, and safety optimization — Europe PMC PMID:41704700

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704700
DOI
10.3389/fmed.2026.1728162
License (as archived)
solo-consultazione
Archived
2026-11-06T07:52:00.743Z
SHA-256 of the archived text
0b70d161c6be65209480addc405c257e0a96bd42a773e547d98be2fddda08093
Stable URL of this page
https://metraipolis.com/documento/dc_580be2af7829

How to cite

Tripterygium glycosides: recent advances in mechanisms, therapeutic applications, and safety optimization — Europe PMC PMID:41704700 — Europe PMC (en), https://europepmc.org/article/MED/41704700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_580be2af7829 (Metraipolis archive dc_580be2af7829, sha256 0b70d161c6be65209480addc405c257e0a96bd42a773e547d98be2fddda08093)
BibTeX
@misc{dc580be2af7829,
  title = {Tripterygium glycosides: recent advances in mechanisms, therapeutic applications, and safety optimization — Europe PMC PMID:41704700},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704700},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_580be2af7829; sha256 0b70d161c6be65209480addc405c257e0a96bd42a773e547d98be2fddda08093},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704700. Agents can read the archived copy with the MCP tool read_document.